Session 5 -_therapeutic___obesity_diabet

2,089 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,089
On SlideShare
0
From Embeds
0
Number of Embeds
932
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Session 5 -_therapeutic___obesity_diabet

  1. 1. Therapeutic Nutrition and Small Animal Nutritional Diseases I
  2. 2.  Formulated for nutritional management of diagnosed disease conditions in dogs and cats  NOT intended to cure disease conditions
  3. 3.  Disease: any bodily abnormality or failure to function properly, except that resulting directly from physical injury  Acute: having a sudden onset, sharp rise, and short course  Chronic: marked by long duration or frequent recurrence
  4. 4.  Clinical: diagnosable by or based on clinical observations.  Sub-clinical: not detectable by the usual clinical observations.
  5. 5.  Nutrients of concern and other food characteristics that make them useful as a nutritional aid to specific disease management or prevention goals  KNFs are either increased or decreased in therapeutic nutritional formulas based on research
  6. 6. Adjusted to help bring about desired outcome:  Improve or maintain nutritional status  Correct deficiency  Gain or lose weight  Rest an organ  Avoid specific food ingredient  Preventive for predisposition
  7. 7.  Prescription Diet® (Hill’s Pet Nutrition, Inc.)  Iams Veterinary Diets® (The Iams Company)  Purina Veterinary Diets™ (Nestlè Purina Petcare Company)  Royal Canin™ Veterinary Diets
  8. 8. 1. Disease 2. Goals 3. KNF 4. Products
  9. 9. Therapeutic Nutrition I Obesity Diabetes Mellitus Periodontal Disease Therapeutic Nutrition II Acute Care/Recovery Food Allergies Canine Osteoarthritis Therapeutic Nutrition III GI Disease Lower Urinary Tract Disease Liver Disease Therapeutic Nutrition IV Renal Disease Cancer/Neoplasia Cognitive Dysfunction Syndrome
  10. 10. Clinical Definition: 20% or more over ideal body weight “Rocky” 7 years, M(N) DSH 20# BCS 5/5 (enjoys yoga )
  11. 11.  orthopedic disease,  diabetes mellitus, abnormalities in circulating lipid profiles,  cardiorespiratory disease,  urinary and reproductive disorders,  neoplasia (mammary tumors, transitional cell carcinoma),  dermatological diseases  anesthetic complications. The main therapeutic options for obesity in companion animals include dietary management and increasing physical activity.
  12. 12. Domino 106 lbs Mr. Bojangles, 18 lbs Samantha, 13 lbs Clemmie, 15 lbs Missy 92 lbs Gabby
  13. 13.  Reduce weight (slowly in cats)  Increase satiety (feels full)  Increase lean body tissue Jesse James 40lbs
  14. 14.  Increased fiber  Decreased energy density/fat  Added carnitine Jesse James 40lbs
  15. 15. Primary predisposing factor is OBESITYOBESITY Amadeus, 26 lbs
  16. 16.  Type 1 Diabetes  “Insulin-dependant” lack of insulin production  Type 2 Diabetes “Non Insulin-Dependant” insulin resistance at the peripheral tissues Insulin helps move glucose from the blood circulation into the cell Pancreas
  17. 17. 1. Stabilize blood glucose & reduce fluctuations 1. Reduce weight – slowlylowly in cats 2. Provide balanced formulation
  18. 18. High Fiber Consistent profile Low Carbohydrates High fiber Consistent profile Low Carbohydrates High protein in certain cases
  19. 19. DM Dietetic Management™ OM Overweight Management™ DCO Diabetes/Colitis Management™ Weight Control D™ Optimum Weight Control Canine Weight Control D™ OptimumWeight Control Feline Prescription Diet® w/d Prescription Diet® r/d Prescription Diet® m/d Diabetic HF 18™ Calorie Control CC™ High Fiber Calorie Control CC ™ High Protein
  20. 20. Feline Canine % DMB Purina DM canned Hill’s Prescription Diet m/d canned Purina DCO Hill’s Prescription Diet w/d canned Protein 56.9 52.8 25.26 17.9 Fat 23.8 19.4 12.41 12.7 Fiber 3.65 6.0 7.63 12.4 Carnitine mg/dl n/a 524 ppm n/a 364 ppm
  21. 21. Image Source: Dr. Geneva Acor, DVM
  22. 22. ““any pathologic process that affects theany pathologic process that affects the periodontium, i.e. structures thatperiodontium, i.e. structures that surround and support the tooth gingivae,surround and support the tooth gingivae, cementum, periodontal ligament,cementum, periodontal ligament, alveolar bone”alveolar bone”
  23. 23. PlaquePlaque  Clear, sticky deposit on tooth surface,Clear, sticky deposit on tooth surface, composed of bacteria and salivarycomposed of bacteria and salivary glycoproteins.glycoproteins. GingivitisGingivitis  Inflammation of the gingiva (gum tissue)
  24. 24. Stain  discoloration of the tooth or of toothdiscoloration of the tooth or of tooth accumulated materialsaccumulated materials Tartar (Calculus)Tartar (Calculus)  mineralized plaque that forms a hard shell on tooth surfaces
  25. 25. Tartar is visible to pet owners, but… Bacterial plaque is the most important substrate in the development of periodontal disease. It is a major precursor! *Nutrients, In: Hand, Thatcher, Remillard, Roudebush, ed. Small Animal Clinical Nutrition, 4th Ed. Mark Morris Institute, 2000;483. www.technicianadvances.com
  26. 26. o Reduce precursors to plaque buildup o Provide regular (daily) removal of plaque o Dental Prophylaxis
  27. 27.  Daily tooth brushing is the most effective method of home dental care  Mechanical removal of plaque and tartar via food
  28. 28. 3 Categories of Dental Care Products Method Properties Examples of Products Mechanical fiber enhanced foods/treats; special texture Prescription Diet t/d; Purina DH Dental Health; Greenies; Nylabone Antibacterial use Chlorhexidine as bacteriostatic or bacteriocidal agent CET Chews & Toothpaste; Nolvosan Chelating Use Hexametaphosphate to bind calcium in saliva to prevent tartar Iam’s Daily Dental Care
  29. 29. Therapeutic Nutrition II: Acute Care/Recovery Food Allergies Canine Osteoarthritis

×